Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial

por Mecinaj, A, Gulati, G, Heck, SL, Holte, E, Fagerland, MW, Larsen, AI, Blix, E.S, Geisler, J, Wethal, T, Omland, T
Publicado 2021